Viscoelastic Measurement of Clot Formation: A New Test of Platelet Function
|
|
- Esmond Sutton
- 5 years ago
- Views:
Transcription
1 ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 2 Copyright 1983, Institute for Clinical Science, Inc. Viscoelastic Measurement of Clot Formation: A New Test of Platelet Function ABDUS SALEEM, M.D.,* CINDY B LIFELD, M.D., SALWA A. SALEH, M.D., DAVID H. YAWN, M.D., MYLES L. MACE, Ph.D, MARY SCHWARTZ, M.D., and E. STANLEY CRAWFORD, M.D. Departments of Pathology, Pediatrics, Anesthesiology and Surgery, Baylor College of Medicine and The Methodist Hospital, Houston, TX ABSTRACT Assessment of platelet function presents a challenge to the investigators in the clinical field. An instrum ent, Sonoclot, is described which measures changes in the viscoelastic properties (clot im pedance on a vibrating probe) of plasma as it is recalcified. Platelet poor plasma (PPP) and platelet rich plasma (PRP) show distinct and characteristic Sonoclot tracings. Tracings of PPP show a lag period and a primary wave. T hese param eters correspond to recalcification tim e and fibrin polymerization. Tracings of PRP show, in addition, a secondary wave and a downward wave. These parameters correspond to the incorporation of platelets in the clot and retraction of the clot. The PRP param eters are influenced by the num ber and quality of the platelets. This instrum ent was utilized to assess the platelet function in patients after coronary artery bypass surgery (CAB). In 69 patients studied, 20 patients did not have excessive bleeding. The clot im pedance tracings in this group were normal. Twenty-four patients had excessive bleeding, normal clot impedance, and coagulation tests indicating the possibility of surgical bleeding. This was confirmed in 22 (92 percent) patients upon exploration to control bleeding. Twenty-five patients had excessive bleeding, normal coagulation tests and abnormal clot im pedance suggesting platelet dysfunction. In twenty-one (84 percent) of the patients, transfusion of platelet concentrate controlled the bleeding with corresponding correction of clot impedance. Sonoclot studies are quick and easy to perform, and appear to be a valuable and reliable adjunct in the diagnosis of hemostatic problems after CAB surgery. Introduction ated on for coronary artery bypass surgery (CAB), not only in large institutions In the last decade there has been an increase in the number of patients oper- but also in smaller community hospitals. Address reprint requests to Abdus Saleem, M.D., Im provem ent in surgical techniques have M.S. #205, The Methodist Hospital, 6565 Fannin, significantly reduced the m orbidity and Houston, TX mortality of this procedure. However, /83/ $01.50 Institute for Clinical Science, Inc.
2 1 16 SALEEM, BLIFELD, SALEH, YAWN, MACE, SCHWARTZ, AND CRAWFORD uncontrollable bleeding rem ains one of the serious com plications, and the incidence of life threatening hemorrhage has been reported to be betw een five to 20 percent. The cause of excessive bleeding may be surgical, hemostatic failure, or both. Several recent studies have em phasized platelet dysfunction as a major cause of hemostatic defect.4,5,6,8 9 Although recent advances in coagulation technology provide valuable inform ation on clotting factor defects, the evaluation of platelet dysfunction remains insensitive and time consuming. The platelet count provides a num erical b u t not qualitative index. Template bleeding time, although superior to older techniques of m easuring bleeding time, is subject to w ide variation in precision.7 Platelet aggregation tests are tim e consum ing and the interp retatio n of resu lts is g enerally subjective.2 The Thromboelastograph has been reported to measure platelet function.10 Its utility is lim ited by the requirem ent of large blood volumes and difficulty with data collection and interpretation.11 The system* provides an insight into platelet function. Basically, the instrument measures changes in the viscoelastic properties (clot im pedance upon vibrating probe) of plasma or whole blood as it is recalcified. The instrum ent is a simple viscoelastometer in series with an analog recorder. It has been used previously by von Kaulla to examine overall coagulability11 and, more recently, others have used it to m onitor heparin adm inistration.3 However, its use has not been generalized and it has not been used specifically to assess platelet function. In this paper, technical data are presented as well as theoretical considerations generated by clot impedance tracings and its application in m onitoring * Sonoclot, manufactured by Sienco Inc., Morrison, CO. p la te le t fu n ctio n follow ing coronary artery bypass surgery. Our specific objective was to determine: (1) if the instrument s tracings correlate with platele t function, and (2) if th e abnorm al tracings correlate w ith excessive bleeding in patients with platelet dysfunction, and if it normalizes after platelet transfusion. Materials and Methods T h e I n s t r u m e n t As previously described11 the instrum ent has a continuously vibrating probe (am plitude less than one micron, frequency less than 200 Hz) partially imm ersed in a m edium of static or changing viscoelastic properties. A mechanical impedance is im posed upon the probe by the medium. Any change in viscoelastic properties of the m edium is reflected in a change in mechanical im pedance. This change is converted to analog output and recorded on th e adjacent chart. A fter calibration against a set of standards, the instrum ent has the capacity to measure relative viscosity. T h e T e s t The blood was collected in a Vacutainer containing 3.8 p ercen t sodium citrate, maintaining a ratio of blood: anticoagulant of 9:1. T he specim en was placed in a centrifuge and spun at 100 x g for 10 m inutes to obtain p la te le t rich plasma (PRP). Further centrifugation of the rem aining contents at 1000 x g for 15 m inutes y ield ed p latelet poor plasm a (PPP). Unless specified, all tests w ere performed as follows: F o u r h u n d re d /u.1 o f sam p le w ere placed in a cuvet containing a stir bar and were equilibrated to 37 C for three minutes. Tw enty /u.1 of 0.5 M C ac l2 w ere added to the plasma. The mixture was stirred for 5 seconds and the probe was
3 then carefully low ered into the cuvet. The recorder was activated. N o r m a l R a n g e Tw enty healthy donors w ith no history of anticoagulant drug use or of a bleeding disorder were used to define the normal Sonoclot tracing and the effect of clotting factor and platelet concentration on the viscoelasticity of platelet poor plasma. E f f e c t o f C a l c i u m C o n c e n t r a t i o n A stock solution of 0.5 M CaCl2 was diluted in distilled water such that 20 /u.1 were added to each of test plasma to yield final concentrations of 0.006, 0.010, 0.020, and M CaCl2. E f f e c t o f T h r o m b i n C o n c e n t r a t i o n A stock solution of throm bin at 100 U p e r m l was m ade by re c o n stitu tin g throm bin in distilled water. Further dilutions were made such that 20 x\ were added to each 400 u.1 of test plasma to yield final throm bin concentrations of 0.16, 0.31, 0.63, and 1.25 U per ml. No CaCl2 was added. E f f e c t o f F a c t o r D e f i c i e n t P l a s m a Factor II, V, VII, VIII, IX, X, XI, XII, and XIII deficient plasm as w ere obtained. Four hundred /xl of each of these plasmas were recalcified with 20 1 of 0.5 M CaCl2. A 25 percent factor concentration of each of the previously m entioned factors was prepared by mixing three parts of factor deficient plasma w ith one part of pooled normal PPP. Each of these substrates was run as previously described. E f f e c t o f P l a t e l e t C o n c e n t r a t i o n A platelet count was obtained on a fresh platelet concentrate from the blood bank. This was appropriately d ilu ted VISCOELASTIC MEASUREMENT OF CLOT 1 17 with analogous plasma to obtain platelet counts of 0, 15, 30, 60, 88, or 250 K per ju.1. Each of these samples was run as previously stated. S o n i c a t e d P l a t e l e t s Platelet rich plasma adjusted to 250 K platelets per / I was sonicated in a Bonwill sonicator with a red probe for two intervals of 15 seconds each. Absence of intact platelets was confirmed by phase contrast microscopy. O u t d a t e d P l a t e l e t s Three and eight day old platelet concentrates obtained from the blood bank, adjusted to a platelet count of 250 K per / I with pooled PPP, were run as previously stated. P a t i e n t s Excessive bleeding after coronary artery bypass surgery is defined as blood loss of greater than 100 ml p er hour. Sixty-nine p atients, adm itted to T he M ethodist H ospital for coronary artery bypass surgery, w ere studied. All patients had a pre-operative screening test consistin g of b le e d in g tim e, p la te le t count, Prothrom bin tim e, (PT), partial throm boplastin time, (PTT), fibrinogen and clot im pedance tracing. Postoperatively, all patients were studied with an identical screen w ithin one hour, or at the tim e of excessive hemorrhage. Patients with abnormal pre-operative screens, history of oral anticoagulants, or antiplatelet drugs w ithin seven days prior to surgery were excluded. Patients who had excessive post-operative bleeding attributable to coagulation factor defects (coagulation factor deficiency, prolonged PT, PTT, and inadequate heparin neutralization) w ere also excluded from this study. In this study, 20 patients did not have excessive bleeding as defined previously
4 118 SALEEM, BLIFELD, SALEH, YAWN, MACE, SCHWARTZ, AND CRAWFORD (controls), while 49 patients showed excessive post-operative bleeding. Results C l o t I m p e d a n c e o f P l a t e l e t P o o r P l a s m a Following recalcification of PPP there was a lag period (A), followed by an upward deflection (primary wave, B). The primary wave reached a plateau at C as shown in figure 1. C l o t I m p e d a n c e o f P l a t e l e t R i c h P l a s m a In addition to lag period (A) and primary wave (B), the recalcification of PRP produced a shoulder (C). This was followed by a secondary wave (D) which, after reaching a peak (E), was followed by a downward deflection (F), (figure 1). N o r m a l R a n g e In table I are shown m ean ± 1 SD of various parameters of the clot im pedence data obtained from PPP and PRP of 20 normal donors. It is dem onstrated that for PRP the lag p erio d was significantly shorter and the primary slope was significantly steeper than those of PPP (p < 0.01). As shown earlier, the instrum ent tracing of PPP did not produce a secondary wave and, therefore, no shoulder peak interval. E f f e c t o f P l a t e l e t C o n c e n t r a t i o n o n C l o t I m p e d a n c e In figure 2 are shown a series of tracings at different platelet concentrations. It will be noted that (1) the lag phase decreased with increase in platelet count; (2) the slope of the primary wave increased with increase in platelet count; (3) the secondary wave made its appearance at 30 K p er fil p latelets; (4) the downward wave appeared at 60 K per / I platelets; and (5) with increasing platelet count, the slope of the secondary wave increased and the shoulder to peak interval decreased. TABLE I Normal Range of Parameters* Lag P e r io d S e c o n d s 1 Wave S lo p e c m /m in 2 Wave S lo p e cm/m in S h o u ld e r t o P ea k I n t e r v a l S e c o n d s Minutes F i g u r e 1. Comparison of clot im pedance of platelet rich plasma (PRP) and platelet poor plasma (PPP). A = lag period; B = primary wave; C = shoulder; D = secondary wave; E = peak; and F = downward wave. Platelet poor plasma Platelet rich plasma ± ± 45t 2.3 ± ± ± 30 Note: All values are expressed as mean ± 1 S.D. *Sonoclot (n = 20) tcompared with platelet poor plasma, p < 0.01
5 VISCOELASTIC MEASUREMENT OF CLOT 1 19 wave was apparent. No primary wave was obtained from PPP w hen the throm bin concentration was less than 0.16 U per ml. With higher concentrations of thrombin, i.e., 0.3, 0.6, or 1.2 U per ml, tracings of PPP showed both a lag period and a primary wave. Minutes F ig u r e 2. Effect of increasing concentration of platelets on Sonoclot tracings. A = platelet poor plasma; B = 15 K per / l; C = 30 K per /xl; D = 60 K per /il; E = 8 8 K per / l; and F = 250 K per /til. E f f e c t o f S t o r a g e o n P l a t e l e t s The clot im pedance from three day old blood bank PRP, adjusted to a platelet count of 250 K per /xl, was similar to a tracing obtained from fresh PRP. However, eight day old blood bank PRP produced a tracing resem bling PPP, showing only a lag phase and primary wave. E f f e c t o f S o n i c a t i o n Clot im pedance of plasma containing sonicated platelets showed a lag period and a prim ary wave. No secondary or downward wave was seen. E f f e c t o f C a l c i u m a n d T h r o m b i n C o n c e n t r a t i o n No primary wave was obtained from PPP when the calcium concentration was less than 0.01 M. With concentrations of 0.02 and M C ac l2, th e prim ary E f f e c t o f C l o t t i n g F a c t o r D e f ic ie n c y Clot im pedance from II, V, and VIII- XII deficient plasma did not produce a primary wave. A 25 percent of concentration of each of these clotting factors did produce a lag period and primary wave. However, in each case, the lag period was longer and primary wave slope less steep than normal. The tracings from VII and XIII deficient plasma produced a lag period and a primary wave which were not significantly different from the corresponding parameters obtained from normal PPP. P a t ie n t s All patients had normal pre-operative bleed in g tim es, PT, PTT, fibrinogen, p la te le t counts, and clot im p ed an ce tracings. In table II are shown the postoperative clinical and laboratory parameters. All patients in the Control group (Group A) had normal clot im pedance. In the group w ith in c re a se d p o st-o p erativ e blood loss, 24/49 patients had normal clot im pedance (Group B), while 25/49 had abnormal clot im pedance (Group C). The cardiopulmonary bypass time in all three groups did not show any significant differences. C o m p a r i s o n o f G r o u p B w i t h C o n t r o l s ( G r o u p A) Maximum post-operative bleeding per hour was significantly higher (p < 0.01) in group B patients (table II). The pum p time, bleeding time, platelet count, and
6 120 SALEEM, BLIFELD, SALEH, YAWN, MACE, SCHWARTZ, AND CRAWFORD TABLE II Post-operative Clinical and Laboratory Data on 69 Patients After Coronary Artery Bypass Surgery Maximum Tem plate Sonoclot P aram eters pump P o s t- o p. P l a t e l e t B le e d in g 1 Wave 2 Wave S h o u ld e r- Time B lood L oss Count Time L ag S lo p e S lo p e p e a k Time M in u te s m l/h o u r k / \ i l M in u tes Seconds cm /m inute cm /m inute Seconds Normal range Controls Group A (n = 20) Group B (n = 24) Group C (n = 25) N/A N/A 60 ± ±130* 275 ± ± ± ± :± t ± ± ± ± ± ± ± ± 25*+ 8.0 ± 4.2* 450 ± 60* * 1.7± 0.4* 325 ±40* Note: All values are expressed as mean ± 1 S.D. *p < 0.01 compared with controls. +p < 0.01 compared with normal. the lag, primary, and secondary wave, and shoulder to peak interval, did not show any statistical difference (p > 0.05). C l i n i c a l F o l l o w - u p o f G r o u p B P a t i e n t s B ecause o f excessiv e h em o rrh ag e, normal bleeding tim e, PT and PTT, and normal clot im pedance, surgical bleeding was suspected in all Group B patients. All patients in this group (24/24) were explored surgically. In 22/24 patients, one or more bleeding vessels w ere detected. These vessels w ere ligated, resulting in satisfactory hemostasis. In 2/24 patients, no bleeding vessels were found. However, the b leed in g tap ered off w ithin two hours of exploration. All patients in this group had blood loss replaced by packed red cells and fresh frozen plasma. C o m p a r i s o n o f G r o u p C w i t h C o n t r o l s ( G r o u p A) Maximum post-operative bleeding was significantly higher (p < 0.01) in Group C patients than in the Control Group. The platelet count was lower and bleeding time was greater than the Control Group. Clot im pedance data show ed abnormalities of all the parameters (table I). The lag phase was longer, the slopes of p rim ary an d seco n d ary w aves w ere lower, and shoulder to peak interval was longer than the Controls (p < 0.01). The clot im pedance abnormalities were more severe than would be expected for the level of platelet count. F o l l o w - u p o f G r o u p C P a t i e n t s Because o f prolonged bleeding tim e and clot impedance abnormalities, platelet dysfunction was suspected to be the cause of excessive bleeding. Ten units of platelet concentrate were adm inistered to all patients (25/25) in this group; the blood loss was replaced by packed red cells and fresh frozen plasma. In 18/25 patients, the b leeding was controlled within 30 minutes of the platelet transfusion. In figure 3 are shown clot impedance tracings of one of the patients before and after platelet transfusion. In 3/25 patients, the response was less dramatic; however, after platelet transfusion, th e b le e d in g ta p e re d off w ith in tw o hours. In 4/25 patients, th e b leed in g continued, and surgical exploration did not reveal any localized bleeding. The bleeding ultimately tapered off in four to
7 Minutes F i g u r e 3. C lot im pedance of p la te le t rich plasma from patient after coronary artery bypass surgery. A = after surgery; B = after transfusion with platelet concentrate. See text for details. 12 hours after exploration. The clot impedance parameters returned to normal in all patients (25/25) after platelet transfusion. Discussion As th e se d ata show, th e com plex coagulation process can be followed from thrombin generation through clot retraction. Clot im pedance tracing curves of PPP and PRP are distinct and reproducible. While the exact determ inants of all phases of the tracing are not known, the basis can be postulated of many of the im p ed an ce changes and som e o f the findings can be correlated w ith a clinical setting. The generation of the clot im pedance tracing is dependent upon multiple factors. Tracings of PPP demonstrate that VISCOELASTIC MEASUREMENT OF CLOT 121 the process begins with fibrin monomer formation, whether it be from the addition of exogenous throm bin or utilization of the throm bin generating capacity of calcium. Our experim ents indicate that the concentration of factors II, V, VIII, IX, X, XI, and XII affects the lag period and the prim ary wave param eters. In contrast, factor VII and XIII have no effect. The Sonoclot distinctly differentiates the PPP from PRP. In fact, the instrum ent has been utilized primarily for assessing platelet function. Q uantitative dependence is dem onstrated in the series of curves g e n e ra te d in fig u re 2. T hus, platelet count is a necessary param eter if the tracings are able to be correlated with implications about platelet function. The lag period of PRP is significantly shorter and the prim ary wave slope is significantly steep er than that of PPP (figure 1 and table I). In addition, PPP does not show the secondary and downward waves present in PRP. From the experim ent presented, it was noted by the present authors that secondary and downward waves made their appearance at a platelet concentration of 30 K and 60 K per / I, respectively. At higher platelet counts, the complex, consisting of the secondary and downward waves, became more compact. Electron microscopic studies of the clot at the tim e of production of the secondary wave revealed that the platelets became an integral part of the clot, and fibrin threads became attached to the platelet surface (figure 4). At about the same time, a visual inspection revealed the clot retracting from the sides of the cuvet. This phenomenon appeared to correspond to the stimulation of contractile protein of the platelets and the contraction of the cytoplasm toward the center of the platelet. It is believed that these events increased the clot density w hich is reflected in the production of the secondary wave. About the time the secondary wave peaked, the
8 SALEEM, BLIFELD, SALEH, YAWN, MACE, SCHWARTZ, AND CRAWFORD 122 F 4. Scanning electron micrograph of a recalcified normal platelet rich plasma showing attach ment of fibrin threads to clumps of activated platelets (x22,000). F 5. Scanning electron micrograph of a recalcified platelet rich plasma from a patient with platelet dysfunction showing poor attachment of fibrin threads to inactive platelets ( x22,000). ig u r e ig u r e
9 clot appeared to have com pletely retracted onto the probe. Thus, the system then consisted of a new probe, the clot plus th e original p robe, v ib ratin g in serum. Serum was a medium low of viscoelasticity. This resulted in production of the downward wave of the Sonoclot tracing. Absence of the secondary and downward waves in the tracing of eight day old blood bank and sonicated platelets indicated th at biologically active and intact platelets w ere necessary for this part of the tracing. The absence of the secondary wave below 30 K platelets per /a1 and absence of the dow nw ard wave below 60 K platelets per ul, roughly correlated with the clinical observation of increased risk of bleeding and prolonged bleeding time at low platelet counts. In figure 2 it is shown that the concentration of platelets influenced the lag period, the slopes of primary and secondary wave, and the duration of the secondary wave (shoulder to peak interval). Since the clotting factor deficiencies also affected the lag period and primary wave slope, the secondary wave slope and shoulder peak interval appeared to be specific for platelet function. The shoulder to peak interval was easily m easured on the chart recorder and may be the m ore conven ien t p aram eter to define platelet function. In our study, 20 patients did not bleed excessively (less than 100 ml per hour) following CAB, and had normal PT, PTT, bleeding tim e and Sonoclot parameters. The platelet count was decreased (200 ± 38 K per il). In 24 patients, surgical bleeding was suspected because of excessive bleeding in face of normal coagulation values, b leed in g tim e, and clot impedance. In 22 (92 percent) patients, surgical bleeding was confirm ed upon re-exploration. In two patients (8 p ercent), the tracings w ere normal, and no surgical bleeding was found. This could represent either failure to predict correctly or difficulty in locating a bleeding VISCOELASTIC MEASUREMENT OF CLOT 123 vessel. In 25 patients w ith excessive bleeding following CAB, p latelet dysfunction was suspected because of abnormal bleeding tim e and/or clot impedance and normal coagulation values. Electron microscopic study of the patients w ith severe platelet dysfunction showed that platelets participated poorly in clot formation and interaction betw een fibrin and platelets was suboptimal (figure 5). Tw enty -one (84 percent) responded clinically to platelet transfusion, and the tracings returned to normal. In 4 (16 percent) patients, the response to platelet transfusion was either delayed or inconclusive despite im provem ent in the viscoelastic abnorm alities of the clot. No surgical bleeding was dem onstrated in these cases. These patients represented a diagnostic dilemma. It is probable that a com bination of surgical defect, platelet dysfunction, and/or vascular dysfunction, was responsible for excessive bleeding. Several investigations have used bleeding tim e as a prim ary test for platelet dysfunction.4,5,8 In our study, although the mean bleeding time was significantly prolonged in patients with platelet dysfunction, several patients had bleeding tim e w ithin normal limits. The shoulder to peak interval dem onstrated a m uch better separation of the groups with normal or abnormal platelet function. Moreover, in peri-operative patients with several intravenous lines, it is often difficult to find a site to do a b leed in g tim e. Often the intravenous infusion had to be discontinued temporarily or the shoulder area had to be used w ithout tourniquet to do bleeding times. The study was relatively easy to perform, and th e resu lts w ere gen erally available w ithin 20 m inutes after the specim en was received in the laboratory. Since PT, PTT, and platelet count results w ere also available within a short tim e, it was possible to indicate whether the patient had a surgical or hemostatic defect. A quick answer to this difficult question
10 1 2 4 SALEEM, BLIFELD, SALEH, YAWN, MACE, SCHWARTZ, AND CRAWFORD a le rte d th e e n tire team of surgeons, anesthesiologists, blood bankers, and coagulationists to institute specific therapy for life threatening hemorrhage. References 1. B ic k, R. L.: Alteration of hemostasis associated with cardiopulmonary bypass. Pathophysiology, prevention, diagnosis and management. Sem. Thromb. Haemost. 3:59 82, C r o n b er g, S.: Evaluation of platelet aggregation. Coagulation 3: , E n s, G. and H e m s t r a, R.: ReAct test. Recalcification of activated whole blood using the Sonoclot. Thromb. Haemost. 38:282, F r i e d e n b e r g, W. R., M y e r s, W. O., P l o t k a, E. D., B e a t h a r d, T. N., K u m m e r, D. J., G a t l in, P. F., S t o ib e r, D. L., R a y, J. F., Ill, and S a u t t e r, R. D.: Platelet dysfunction associated with cardiopulmonary bypass. Ann. Thorac. Surg. 25: , H a r k e r, L. A., M a l p a s s, T. W., B r a n s o n, H. E., H a s s e l, E. A., II, and S l ic h t e r, S. L.: Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient p la te let dysfunction associated w ith selective granule release. Blood 56: , H e n n e s s y, V. L., H ic k s, R. E., N ie w ia r o w s k i, S., E d m u n d s, L. H., Jr., and C o l e m a n, R. W.: Function of human platelets during extracorporeal circulation. Amer. J. Physiol. 232: , H i r s h, J., B l a jc h m a n, M., and K a e g i, A.: The bleeding time. Platelet Function Testing. Day, H. J., Holmsen, H., and Zucker, M. B., eds. Washington, U.S. Department of Health, Education and Welfare, 1978, pp M c K e n n a R., B a c h m a n n, F., W h i t t a k e r, B., G i l s o n, J. R., and W e i n b e r g, M., Jr.: The hem ostatic m echanism after open heart surgery. II. Frequency of abnormal platelet function during and after extracorporeal circulation. J. Thorac. Surg. 70:76-85, U m l a s, J.: In vivo platelet function following cardiopulmonary bypass. Transfusion i5 : , von Kau lla, K. N.: Quantitative methods for recording blood coagulation: theoretical and practical aspects. Progress in Hematology III, New York, G rune and Stratton, 1962, pp v o n K a u l l a, K. N., O s t e n d o r f, P., and v o n K a u l l a, E.: The impedence machine: A new bedside coagulation recording device. J. Med. 6:73-87, 1975.
A Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
ANNALS O F CLINICAL AND LABORATORY SC IEN CE, Vol. 20, No. 1 Copyright 1990, Institute for Clinical Science, Inc. A Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
More informationReemergence of the International Normalized Ratio for the Standardization of Prothrombin Time*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 23, No. 3 Copyright 1993, Institute for Clinical Science, Inc. Reemergence of the International Normalized Ratio for the Standardization of Prothrombin
More informationLONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey. Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France
LONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France Prof Ercan Ok Divis ion of N ephrology E ge U nivers ity
More informationSensitivity of Serum Fructosamine in Short Term Glycemic Control
A N N A L S O F C L IN IC A L A N D L A B O R A T O R Y S C IE N C E, Vol. 19, N o. 2 Copyright 1989, Institute for Clinical Science, Inc. Sensitivity of Serum Fructosamine in Short Term Glycemic Control
More informationAcquired Coagulopathy Owing to Parenteral Cefamandole: Renal Failure as a Predisposing Factor*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 5 Copyright 1983, Institute for Clinical Science, Inc. Acquired Coagulopathy Owing to Parenteral Cefamandole: Renal Failure as a Predisposing Factor*
More informationH yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 4 Copyright 1985, Institute for Clinical Science, Inc. H yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume Use
More informationHEMOSTASIS Quality Time saving Economy Practicability Quality assurance Precision
Quality Time saving Economy Practicability Quality assurance Precision exclusive distributor of for France, Netherlands, Belgium and Luxembourg List of frozen reagents In 1992, Precision BioLogic began
More informationBleeding, Coagulopathy, and Thrombosis in the Injured Patient
Bleeding, Coagulopathy, and Thrombosis in the Injured Patient June 7, 2008 Kristan Staudenmayer, MD Trauma Fellow UCSF/SFGH Trauma deaths Sauaia A, et al. J Trauma. Feb 1995;38(2):185 Coagulopathy is Multi-factorial
More informationEffects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task
Effects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task R obert S. K ennedy*, Janet J. Turnage*, D eborah L. H arm ** and Julie M. Drexler*** *Essex Corporation,
More informationInstruments smart solutions & service IGZ Instruments AG Räffelstrasse 32 CH 8045 Zürich
ADP (Adenosine-5 -Diphosphate) 101312 3 x 0.5mL ADP is a lyophilized preparation of adenosine-5 -diphosphate. The working concentration of the reconstituted reagent is 2 x 10-4 M. ADP is for use in routine
More informationBleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon
Bleeding and Haemostasis Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon 1 Beeding Its escaping or extravasation of blood contents from blood vessels Types: - Arterial - Venous - Capillary Differences
More informationApproach To A Bleeding Patient
ABDUL MAJEED, RAHUL RAJEEV REVIEW ARTICLE INTRODUCTION Hemostasis is the process of forming clots in the walls of damaged blood vessels and preventing blood loss while maintaining blood in a fluid state
More informationUNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.
UNIT VI Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav Hemostasis: Prevention of Blood Loss Vascular constriction Formation of a platelet plug Formation of a blood
More informationL iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche
L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University
More informationCoagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University
In The Name God Coagulation an Overview Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Research hcenter Shiraz Medical University Bleeding Clotting Hemostasis Review of platelet function Platelets
More informationRoutine preoperative coagulation tests: are they necessary?
Routine preoperative coagulation tests: are they necessary? Dr Azzah Alzahrani MD Pediatrics Hematology /Oncology PSMMS Outline Introduction. Brief review of hemostatic mechanisms. A clinical aspect of
More informationProblems with Outliers in Breath Alcohol Testing
Problems with Outliers in Breath Alcohol Testing Jo c h e n W ilske Blood alcohol concentration (BAC) and impairment o f driving skills are related so closely, that statutory drink-drive limits are accepted
More informationLifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.
LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual
More informationADMINISTRATIVE CLINICAL Page 1 of 6
ADMINISTRATIVE CLINICAL Page 1 of 6 Anticoagulant Guidelines #2: REVERSAL OF OR MANAGEMENT OF BLEEDING WITH ANTICOAGULANTS Origination Date: Revision Date: Reviewed Date: 09/12 09/12, 01/13, 11/13, 11/15
More informationThis slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion
This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms
More informationA Percent Correction Formula for Evaluation of Mixing Studies
Coagulation and Transfusion Medicine / A PERCENT CORRECTION FORMULA FOR EVALUATION OF MIXING STUDIES A Percent Correction Formula for Evaluation of Mixing Studies Sheng-hsiung Chang, MD, Veronica Tillema,
More informationHow can ROTEM testing help you in cardiac surgery?
How can ROTEM testing help you in cardiac surgery? Complicated bleeding situations can appear intra and post operatively. They can be life-threatening and always require immediate action. A fast differential
More informationThromboelastography Use in the Perioperative Transfusion Management of a Patient with Hemophilia A Undergoing Liver Transplantation
Open Journal of Organ Transplant Surgery, 2013, 3, 13-17 http://dx.doi.org/10.4236/ojots.2013.31003 Published Online February 2013 (http://www.scirp.org/journal/ojots) Thromboelastography Use in the Perioperative
More informationAnatomy and Physiology
Anatomy and Physiology For The First Class 2 nd Semester Thrombocytes = Platelets Thrombocytes = Platelets Blood platelets are non-nucleated disc like cell fragments 2-4 µm in diameter. Platelets are not
More informationE levated Prolactin Level in Prostates with Latent Carcinoma
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 3 Copyright 1987, Institute for Clinical Science, Inc. E levated Prolactin Level in Prostates with Latent Carcinoma RYUICHI YATANI, M.D.,* ITSUO
More informationPart IV Antithrombotics, Anticoagulants and Fibrinolytics
Part IV Antithrombotics, Anticoagulants and Fibrinolytics "The meaning of good and bad, of better and worse, is simply helping or hurting" Emerson Chapter 16: Blood Coagulation and Fibrinolytic System
More informationFresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation
Fresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation Elizabeth A. Gilman, MD, 1 Christopher D. Koch, 1 Paula J.
More informationClinical Trial of Young Red Blood Cells Prepared by Apheresis
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 16, No. 6 Copyright 1986, Institute for Clinical Science, Inc. Clinical Trial of Young Red Blood Cells Prepared by Apheresis PATRICIA PISCIOTTO, M.D.,* THOMAS
More informationRapid Enzymatic Determination of Amylase in Serum and Urine Using a Centrifugal Analyzer*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 5 Copyright 1979, Institute for Clinical Science, Inc. Rapid Enzymatic Determination of Amylase in Serum and Urine Using a Centrifugal Analyzer* STEVEN
More informationControlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in Advanced Parkinson s Disease
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, No. 2 Copyright 1989, Institute for Clinical Science, Inc. Controlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in
More informationStep 2. Common Blood Tests, and the Coulter Counter Readout
Step 2. Common Blood Tests, and the Coulter Counter Readout We will be learning about some common blood tests. We will not be preforming most of them in lab. The student should know their names, their
More informationMohammadreza Tabatabaei IBTO COAG LAB
Tests for the Evaluation of Lupus Anticoagulants t Mohammadreza Tabatabaei MSc Hematology blood bank MSc Hematology blood bank IBTO COAG LAB Lupus Anticoagulants General Background Lupus anticoagulants
More informationNew Age Anticoagulants: Bleeding Considerations
Ontario Regional Blood Coordinating Network March 23, 2012 New Age Anticoagulants: Bleeding Considerations Bill Geerts, MD, FRCPC Thromboembolism Specialist, Sunnybrook HSC Professor of Medicine, University
More informationApproach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate
Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:
More informationProthrombin Complex Concentrate- Octaplex. Octaplex
Prothrombin Complex Concentrate- Concentrated Factors Prothrombin Complex Concentrate (PCC) 3- factor (factor II, IX, X) 4-factor (factors II, VII, IX, X) Activated 4-factor (factors II, VIIa, IX, X) Coagulation
More informationTRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006
TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 CTU blood product transfusion guidelines 2006 1 Summary of guidelines RED CELLS (10-15ml/kg) This applies to ward patients / icu patients who are stable.
More informationM B Garvey. University of Toronto
Do I really need that test??? M B Garvey Professor Emeritus University of Toronto St Michael s Hospital No relevant conflicts of interest 1 HEMOSTASIS IS LIKE LOVE Everybody talks about it, nobody understands
More informationScreening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions
Screening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions C arl A. S o d e r str o m, M.D.,1 P a tricia C. D isc h in g e r, P h.d.,2 G ord on S. S m ith, M.D.3
More informationAn Assay for Monitoring Response to Therapy in Cancer Patients*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 3 Copyright 1993, Institute for Clinical Science, Inc. An Assay for Monitoring Response to Therapy in Cancer Patients* CALVIN C. W ILH ID E, P h.d.tt
More informationThrombosis and Coagulation Abnormalities Associated with Cancer
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 24, No. 1 Copyright 1994, Institute for Clinical Science, Inc. Thrombosis and Coagulation Abnormalities Associated with Cancer ARMAND B. GLASSMAN, M.D. and
More informationDetermination of Acid Phosphatase Activity in Normal Human Lymphocytes
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 1 Copyright 1982, Institute for Clinical Science, Inc. Determination of Acid Phosphatase Activity in Normal Human Lymphocytes PAUL I. LIU, M.D.,
More informationCoagulation Defects and Bleeding in Open-Heart Surgery
Coagulation Defects and Bleeding in Open-Heart Surgery Enrique E. Signori, M.D., John A. Penner, M.D., and Donald R. Kahn, M.D. H emorrhagic diathesis associated with extracorporeal circulation has been
More informationDubbi e certezze nella gestione delle emorragie con metodiche point-of-care
Sessione Educazionale 4 : Gestione del paziente emorragico Dubbi e certezze nella gestione delle emorragie con metodiche point-of-care P. Simioni Università di Padova hemostasis Vascular phase Platelet
More informationGLANZMANN S THROMBASTHENIA. Stacey Shiovitz January 13, 2012
GLANZMANN S THROMBASTHENIA Stacey Shiovitz January 13, 2012 HELP!! MY PATIENTHASGT DO YOU EVEN KNOW WHAT THAT IS? CASE 27yo woman presented tdto gynecology clinic i for menorrhagia x 10 days Bleeding started
More informationHemostasis Haemostasis means prevention of blood loss from blood vessels.
١ Hemostasis Haemostasis means prevention of blood loss from blood vessels. Bleeding is stopped by several mechanisms, which are: 1. Local vasoconstriction 2. Formation of platelet plug 3. Blood coagulation
More informationIntroduction to coagulation and laboratory tests
Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises
More informationNEW ONE-STAGE PROCEDURES FOR THE QUANTITATIVE DETERMINATION OF PROTHROMBIN AND LABILE FACTOR*
NEW ONE-STAGE PROCEDURES FOR THE QUANTITATIVE DETERMINATION OF PROTHROMBIN AND LABILE FACTOR* MARIO STEFANINI, M.D.f From the Department ofbiochemistry, Marquette University School of Medicine, Milwaukee,
More informationHemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins
Hemostasis Learning objectives 14-16 Dr. Mária Dux Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostatic balance! procoagulating activity anticoagulating activity 1 Thrombocytes
More informationBehzad Poopak, DCLS PhD
Behzad Poopak, DCLS PhD Test Report Name Age Critical Low HEMATOLOGY Activated Partial Thromboplastin Time, Plasma Critical High - 150 sec Units Fibrinogen 60 - mg/dl INR (International Normalizing
More informationPlatelet Satellitosis: A Case Report with Laboratory Characterization and Quantitative Evaluation*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 2 Copyright 1979, Institute for Clinical Science, Inc. Platelet Satellitosis: A Case Report with Laboratory Characterization and Quantitative Evaluation*
More informationDo Sonoclot Coagulation Parameters Correlate with Thrombelastograph Parameters?
Original Article Do Sonoclot Coagulation Parameters Correlate with Thrombelastograph Parameters? Lem Meherg AS, RRT, Jeffrey B. Riley BA, CCT, Dennis R. Wolk RN, BS Program in Extracorporeal Circulation
More informationBLEEDING DISORDERS Simple complement:
BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder
More informationAdenosine Diphosphate-induced Platelet Aggregation in the States of Hypercoagulability
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 7, No. 2 Copyright 1977, Institute for Clinical Science Adenosine Diphosphate-induced Platelet Aggregation in the States of Hypercoagulability TEH Y. WANG,
More informationHemostasis and. Blood Coagulation
Hemostasis and Blood Coagulation Events in Hemostasis The term hemostasis means prevention of blood loss. Whenever a vessel is severed or ruptured, hemostasis is achieved by several mechanisms: (1) vascular
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091667 Age 37 Years Gender Male 29/8/2017 120000AM 29/8/2017 100129AM 29/8/2017 113851AM Ref By Final COAGULATION ROFILE 1 ARTIAL THROMBOLASTIN TIME, ACTIVATED; ATT
More informationDIAGNOSTIC TESTING IN PATIENT BLOOD MANAGEMENT PROGRAMS
DIAGNOSTIC TESTING IN PATIENT BLOOD MANAGEMENT PROGRAMS The Role of Diagnostic Point-of-Care Testing Diagnostic testing is an essential component of Patient Blood Management. The accurate assessment of
More informationGeneral approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013
General approach to the investigation of haemostasis Jan Gert Nel Dept. of Haematology University of Pretoria 2013 Clinical reasons to investigate haemostasis Investigating a clinically suspected bleeding
More informationWHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT WO NDCLOT. The WoundClot Principals for Effective Bleeding Control PRESENTATION
WHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT ARTICLES OUR STUDY BLEEDING CONTROL 5 POINT MODEL WO NDCLOT The WoundClot Principals for Effective Bleeding Control PRESENTATION Harnessing SCIENCE
More informationThyroid Screening in the Newborn: Utah Experience
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 1 Copyright 1983, Institute for Clinical Science, Inc. Thyroid Screening in the Newborn: Utah Experience BRUCE A. BUEHLER. M.D.,* MELVIN J. GORTATOUSKI,
More informationWhole Blood Viscosity in Beta Thalassemia Minor
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 4 Copyright 1992, Institute for Clinical Science, Inc. Whole Blood Viscosity in Beta Thalassemia Minor JAMES P. CROWLEY, M.D.t, JACLYN B. M ETZGER,
More informationChapter 19. Hemostasis
Chapter 19 Hemostasis Hemostasis Hemostasis is the cessation of bleeding stopping potentially fatal leaks important in small blood vessels not effective in hemorrhage excessive bleeding from large blood
More informationBlood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )
Blood coagulation and fibrinolysis Blood clotting (HAP unit 5 th ) Vessel injury Antithrombogenic (Favors fluid blood) Thrombogenic (Favors clotting) 3 Major systems involved Vessel wall Endothelium ECM
More informationBLEEDING DISORDERS. JC Opperman 2012
BLEEDING DISORDERS JC Opperman 2012 Primary and Secondary Clotting Laboratory Tests Routine screening tests Prothrombin time (PT) (INR) increased in neonates (12-18 sec) Partial thromboplastin time (PTT)
More informationHLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors in Patients with H unter s Syndrom e*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 5 Copyright 1985, Institute for Clinical Science, Inc. HLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors
More informationDVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center
DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the
More informationDr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN
Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN The student should be able:» To identify the mechanism of homeostasis and the role of vessels, platelets
More informationResponse of Red Blood Cell Control Materials to Altered Testing Conditions
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 1 Copyright 1988, Institute for Clinical Science, Inc. Response of Red Blood Cell Control Materials to Altered Testing Conditions MARK E. SHERMAN,
More informationHemostasis Haemostasis means prevention of blood loss from blood vessels.
1 Hemostasis Haemostasis means prevention of blood loss from blood vessels. Bleeding is stopped by several mechanisms, which are: 1. Local vasoconstriction 2. Formation of platelet plug 3. Blood coagulation
More informationPrimary Exam Physiology lecture 5. Haemostasis
Primary Exam Physiology lecture 5 Haemostasis Haemostasis Body s response for the prevention and cessation of bleeding. Broadly consists of: Primary Haemostasis - vascular spasm and platlet plug formation
More informationFurther study has tended to confirm this interpretation.
PROPERTIES OF AN ANTICOAGULANT FOUND IN THE BLOOD OF A HEMOPHILIAC By F. L. MUNRO (From the Charlotte Drake Cardeza Foundation, Department of Medicine, College and Hospital, Philadelphia) Jefferson Medical
More informationHuman Platelet Aggregation and camp System camp Level, Adenyl Cyclase, Phosphodiesterase *
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 5 Copyright 1978, Institute for Clinical Science Human Platelet Aggregation and camp System camp Level, Adenyl Cyclase, Phosphodiesterase * TEH Y.
More information4/23/2009. September 15, 2008
The Current Treatment of Deep Venous Thrombosis: Are We Doing Enough? George H. Meier, MD Professor and Chief Division of Vascular Surgery University of Cincinnati College of Medicine Cincinnati, Ohio
More informationHemostasis and thrombosis in patients with liver disease. Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands
Hemostasis and thrombosis in patients with liver disease Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands Importance of the liver in hemostasis Synthesis of Coagulation factors Fibrinolytic proteins
More informationEffective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)
1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory
More informationPathological Evaluation of WR Administered Orally in Irradiated and Non-Irradiated Male Mice
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 3 Copyright > 1992, Institute for Clinical Science, Inc. Pathological Evaluation of WR-151327 Administered Orally in Irradiated and Non-Irradiated
More informationClinical Overview of Coagulation Testing Issues
Clinical Overview of Coagulation Testing Issues Adam M. Vogel, MD Assistant Professor, Division of Pediatric Surgery Washington University in St. Louis School of Medicine September 19, 2014 Disclosure
More informationHemodialysis (HD) has improved the prospects of. Sonoclot Analysis in Cardiac Surgery in Dialysis- Dependent Patients
CARDIOVASCULAR Sonoclot Analysis in Cardiac Surgery in Dialysis- Dependent Patients Toshihiko Shibata, MD, PhD, Yasuyuki Sasaki, MD, PhD, Koji Hattori, MD, PhD, Hidekazu Hirai, MD, Mitsuharu Hosono, MD,
More information-Hashim ahmed is the one who wrote this sheet. I just edited it according to our record.
* Subjects of this lecture : - Hemostasis - Platelets, general information, their ultrastructure and role in hemostasis. - Definitions: Thrombus, Embolus, Arteriosclerosis and Atherosclerosis. *NOTE: Prof
More informationTopics of today lectures: Hemostasis
Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms of hemostasis - Vascular contraction - Platelets plug - Blood coagulation (clotting) - Structure and functions of platelets - Blood
More informationWelcome to esessions. Presented by CaridianBCT. PN CaridianBCT
Welcome to esessions Presented by CaridianBCT Presentation Overview Definition of TPE Rationale for TPE Role of TPE in the treatment of autoimmune diseases Procedural elements Definition of TPE Removal
More informationGUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS
CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.
More informationMajor Haemorrhage Protocol. Commentary
Hairmyres Hospital Monklands Hospital Wishaw General Hospital Major Haemorrhage Protocol Commentary N.B. There is a separate NHSL protocol for the Management of Obstetric Haemorrhage Authors Dr Tracey
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationThe Effectiveness of ASAP Education and Rehabilitation Programs
The Effectiveness of ASAP Education and Rehabilitation Programs James L. Nichols 1 EDUCATIONAL PROGRAMS B ackground and D escription Educational programs for convicted drinking drivers have recently received
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091668 Age 40 Years Gender Male 29/8/2017 120000AM 29/8/2017 100156AM 29/8/2017 120820M Ref By Final COAGULATION ROFILE 2 FACTOR VIII FUNCTIONAL /ACTIVITY (Electromechanical
More informationBlood platelets play important role in coagulation.
B.N. Bandodkar College of Science, Thane T.Y. B.Sc Paper II Haematology Blood Coagulation / Blood clotting By Dr N.N. Patil Introduction: When blood is shed, it looses its fluidity within few minutes and
More informationThe Assay and Properties of Labile Factor (Factor V)
Marquette University e-publications@marquette Biomedical Sciences Faculty Research and Publications Health Sciences, College of -1-1960 The Assay and Properties of Labile Factor (Factor V) Armand J. Quick
More informationRecombinant Activated Factor VII: Useful. Department of Surgery Grand Rounds 11/8/10 David Mauchley MD
Recombinant Activated Factor VII: Useful Department of Surgery Grand Rounds 11/8/10 David Mauchley MD Hemostasis and Coagulation Traditional cascade model Two convergent pathways Series of proteolytic
More informationPhysiology of. The Blood hemostasis. By prof. Israa f. jaafar
Physiology of The Blood hemostasis By prof. Israa f. jaafar Learning objectives Understand the Platelet structure and function Explane the Platelet production Understand the phases of hemostasis: vascular
More informationBranch of medicine that deals with blood, its formation and disorders is called. Three main functions of cardiovascular system are,, and.
Chapter 19 The Blood Human body must maintain a balance called. Body fluid inside the cells is called fluid; that outside is called or fluid. Two major fluid networks that help in connecting cells are
More informationDo Heparinase Thrombelastographs Predict Postoperative Bleeding?
Original Article Do Heparinase Thrombelastographs Predict Postoperative Bleeding? Paulla Mashburn BS, Jodie Ecklund BS, CCP, Jeffrey Riley BA, CCT, CCP Program in Extracorporeal Circulation Technology,
More informationHeme (Bleeding and Coagulopathies) in the ICU
Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related
More informationclotting is presumably due to a thromboplastin contained in the blood, since significant admixture with tissue thromboplastin can be avoided.
89 J. Physiol. (I953) iig, 89-IOI THE FORMATION OF THROMBOPLASTIN IN HUMAN BLOOD BY ROSEMARY BIGGS, A. S. DOUGLAS AND R. G. MACFARLANE From the Department of Pathology, Radcliffe Infirmary, Oxford (Received
More informationLong-Term Efficacy of Controlled-Release Carbidopa/Levodopa in Patients with Advanced Parkinson s Disease*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, 6 Copyright 1989, Institute for Clinical Science, Inc. Long-Term Efficacy of Controlled-Release Carbidopa/Levodopa in Patients with Advanced Parkinson
More informationChapter 19: Cardiovascular System: Blood
Chapter 19: Cardiovascular System: Blood I. Functions of Blood A. List and describe the seven major homeostatic functions of blood: 1. 2. 3. 4. 5. 6. 7. II. Plasma A. Composition 1. It is a fluid consisting
More informationGUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
More informationA Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase and Hydroxyproline Assays
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 2 Copyright 1978, Institute for Clinical Science A Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase
More informationEffects o f Oral Salt Load on Arginine-Vasopressin Secretion in N orm al Subjects*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 5 Copyright 1987, Institute for Clinical Science, Inc. Effects o f Oral Salt Load on Arginine-Vasopressin Secretion in N orm al Subjects* LETIZIA
More informationManaging Coagulopathy in Intensive Care Setting
Managing Coagulopathy in Intensive Care Setting Dr Rock LEUNG Associate Consultant Division of Haematology, Department of Pathology & Clinical Biochemistry Queen Mary Hospital Normal Haemostasis Primary
More informationWhat s in the Massive Transfusion Protocol (MTP) Package?
What s in the Massive Transfusion Protocol (MTP) Package? The Massive Transfusion Protocol Package is a set of documents intended to improve the coordination of a Massive Transfusion Protocol. The kit
More information